20020602
 Bravo, FDA (Really)   The Wall Street Journal,  Jun 3, 2002  Before this new rule, drugs had to be shown to be both "safe" and "effective" on humans to win FDA approval. That's a near impossible task for some anti-bioterror agents, given that it is unethical to subject humans to life-threatening or permanently disabling compounds. Under the new system, bioterror researchers will in most cases still have to show that a drug is "safe" for humans, which can normally be done without exposing anyone to harm. But whether it is "effective" can now be shown through animal trials.   
